Log In
Print
BCIQ
Print
Print this Print this
 

CYC065

  Manage Alerts
Collapse Summary General Information
Company Cyclacel Pharmaceuticals Inc.
DescriptionSecond-generation inhibitor of cyclin dependent kinases (CDKs) 2E, 2A, 7 and 9
Molecular Target Cyclin dependent kinase (CDK)
Mechanism of ActionCyclin dependent kinase (CDK) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today